G1 Therapeutics, Inc.
USD7.16
+0.01 (+0.14%)
CEO
John E. Bailey Jr.
IPO Date
2017-05-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$7.15
Prev. Close
$7.15
Day Low
$7.14
Day High
$7.16
52W Low
$1.08
52W High
$7.19
Market Cap
$0.38B
Volume
1.10M
| 534,787 |
| $7.15 |
| 18 Sept 2024 | Bailey John E. (Jack) Jr. | director, officer: President and CEO | U-Tender | Disposed | 196,287 | $0.00 |
| 18 Sept 2024 | Bailey John E. (Jack) Jr. | director, officer: President and CEO | D-Return | Disposed | 201,300 | $2.97 |
| 18 Sept 2024 | Bailey John E. (Jack) Jr. | director, officer: President and CEO | D-Return | Disposed | 161,300 | $5.73 |
| 18 Sept 2024 | Nicholson Garry A | director | D-Return | Disposed | 20,000 | $7.15 |
| 18 Sept 2024 | Nicholson Garry A | director | U-Tender | Disposed | 14,389 | $0.00 |
| 18 Sept 2024 | Nicholson Garry A | director | D-Return | Disposed | 30,000 | $2.99 |
| 18 Sept 2024 | Nicholson Garry A | director | D-Return | Disposed | 30,000 | $2.83 |
| 18 Sept 2024 | Nicholson Garry A | director | D-Return | Disposed | 30,000 | $5.30 |